← Back to Patent Explorer
US4177277A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for alleviating hypertension

Assignee: ER Squibb and Sons LLC
•
Filing: 1978-09-15
•
Granted: 1979-12-04
•
Expires: 1998-09-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for alleviating or reducing angiotensin related hypertension in hypertensive mammals comprises administering an effective amount of a compound having the general formula ##STR1## Intermediates for the preparation of such compounds are also included.

Inventors

  • 👤 Miguel A. Ondetti
  • 👤 Michael E. Condon

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 22:06
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06017; C07K5/0606; C07C; C07C327/00; C07D; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/16; C07D207/46; C07D209/00; C07D209/02; C07D209/04; C07D209/10; C07D209/18; C07D209/20; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/60; C07D211/80; C07D211/84; C07D211/86; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 154 words
A method for alleviating hypertension in hypertensive mammals which comprises administering an effective dose of a compound having the formula ##STR15## or salt thereof, wherein R is hydroxy or lower alkoxy R 1 is hydrogen, lower alkanoyl or amino(imino)methyl; R 2 is hydrogen, lower alkyl or phenyl-lower alkylene; R 3 is hydrogen, lower alkanoyl, benzoyl or ##STR16## A is hydrogen, lower alkyl or hydroxy-lower alkylene; B is hydrogen, lower alkyl, phenyl, phenyl-lower alkylene, hydroxy-lower alkylene, hydroxyphenyl-lower alkylene, amino-lower alkylene, guanidino-lower alkylene, imidazolyl-lower alkylene, indolyl-lower alkylene, mercapto-lower alkylene, lower alkylthio-lower alkylene, carbamoyl-lower alkylene or carboxy lower alkylene; or A and B together form a (CH 2 ) p bridge which completes an unsubstituted ring of 5 or 6 atoms with the nitrogen and carbon to which they are joined or said ring substituted with a hydroxy group; m is 1, 2, 3 or 4; n is 0 or 1; and p is 3 or 4.
Claim 2
Independent Claim 154 words
A method for alleviating hypertension in hypertensive mammals which comprises administering an effective dose of a compound having the formula ##STR15## or salt thereof, wherein R is hydroxy or lower alkoxy R 1 is hydrogen, lower alkanoyl or amino(imino)methyl; R 2 is hydrogen, lower alkyl or phenyl-lower alkylene; R 3 is hydrogen, lower alkanoyl, benzoyl or ##STR16## A is hydrogen, lower alkyl or hydroxy-lower alkylene; B is hydrogen, lower alkyl, phenyl, phenyl-lower alkylene, hydroxy-lower alkylene, hydroxyphenyl-lower alkylene, amino-lower alkylene, guanidino-lower alkylene, imidazolyl-lower alkylene, indolyl-lower alkylene, mercapto-lower alkylene, lower alkylthio-lower alkylene, carbamoyl-lower alkylene or carboxy lower alkylene; or A and B together form a (CH 2 ) p bridge which completes an unsubstituted ring of 5 or 6 atoms with the nitrogen and carbon to which they are joined or said ring substituted with a hydroxy group; m is 1, 2, 3 or 4; n is 0 or 1; and p is 3 or 4.
Claim 3
Dependent Claim 19 words
A method as in claim 1 wherein the compound has the L-configuration with respect to the carbon bearing B.
Claim 4
Dependent Claim 38 words
A method as in claim 1 wherein ##STR17## in the formula is the radical of glycine, alanine, leucine, threonine, phenylalanine, lysine, arginine, glutamine, histidine, methionine, serine, cysteine, tyrosine, valine, asparagine, glutamic acid, proline, hydroxyproline, phenylglycine, tryptophane or N-methylphenylalanine.
Claim 5
Dependent Claim 53 words
A method for alleviating hypertension in hypertensive mammals which comprises administering an effective dose of a compound having the formula ##STR18## or salt thereof, wherein R, R 1 , R 2 , R 3 , m and n have the same meaning as in claim 1 and R 4 is hydrogen or hydroxy.
Claim 6
Dependent Claim 27 words
A method as in claim 1 wherein the compound in the formula has A and B together as --(CH 2 ) 4 -- completing a six-membered ring.
Claim 7
Dependent Claim 66 words
A method as in claim 1 wherein the compound in the formula has R as hydroxy; R 1 as hydrogen, lower alkanoyl, or amino(imino)methyl; R 2 as hydrogen, lower alkyl or phenyl-lower alkylene; R 3 as hydrogen, lower alkanoyl or benzoyl; A as hydrogen; B as lower alkyl, guanidino-lower alkylene, amino-lower alkylene or phenyl-lower alkylene; m as 3 or 4 and n as 0 or 1.
Claim 8
Dependent Claim 17 words
A method as in claim 1 wherein the compound in the formula has R 3 as ##STR19##
Claim 9
Dependent Claim 16 words
A method as in claim 1 wherein the compound in the formula has R as hydroxy.
Claim 10
Dependent Claim 31 words
A method as in claim 4 wherein the compound in the formula has R as hydroxy and R 1 , R 2 , R 3 and R 4 each as hydrogen.
Claim 11
Dependent Claim 37 words
A method as in claim 4 wherein the compound in the formula has R as hydroxy, R 1 , R 2 , R 3 and R 4 each as hydrogen, m as 3 and n as 1.
Claim 12
Dependent Claim 38 words
A method as in claim 4 wherein the compound in the formula has R as hydroxy, R 2 , R 3 and R 4 each as hydrogen, R 1 as amino(imino)methyl, m as 3 and n as 1.
Claim 13
Dependent Claim 14 words
A method as in claim 9 wherein m is 2 and n is 1.
Claim 14
Dependent Claim 38 words
A method as in claim 1 wherein the compound in the formula has R as hydroxy, B as isobutyl, A, R 1 , R 2 and R 3 each as hydrogen, m as 3 and n as 1.
Claim 15
Dependent Claim 48 words
A method as in claim 1 wherein the compound in the formula has A and B forming a (CH 2 ) p bridge wherein p is 4, R as hydroxy, R 1 , R 2 and R 3 each as hydrogen, m as 3 and n as 1.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-12-03 1983-06-04 1983-12-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-12-03 1987-06-04 1987-12-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-12-03 1991-06-04 1991-12-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag